Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications response cost meningococcal disease outbreaks university campus settings case study
… 2023 Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain … metastases (mNSCLC) has been published. Research Focus The study focused on patients who had received treatment with the … medical record review, and captured the best overall response rate as well as the duration of response, …
… What Do Patients with Parkinson’s Disease Value Most In Off-Episode Treatments? Share on: … with RTI Health Solutions conducted a patient-preference study using a discrete-choice experiment survey to elicit … to relieve symptoms) How long symptom relief would last Cost Overall, respondents placed the most importance on …
… 6 - Wednesday, February 7, 2024 Meeting website In response to a US Congressional request, an ad hoc committee … Sciences, Engineering, and Medicine (NASEM) will conduct a study in the United States and the European Union on the … MD, PhD, to present at an upcoming meeting for the study. During the Novel Methodologies session, Dr. Garcia de …
… Drug research focuses on treatment differences and disease differences—much to the exclusion of individual … controlled group. However, some patients in your study will benefit more or less than the average. Who are … help you uncover and understand heterogeneity in treatment response among your patients. These efficient methods allow …
… post-market pregnancy requirements and safety in rare disease and gene therapy. Here are the details. #314: … pregnancy registries, alternative observational study designs and methods. The experts will then come … pregnancy studies. #362: Assessing Safety in Rare Disease and Gene Therapy Wednesday, June 28 • 4:00pm - 5:00pm …
… modern psychometric methods, including those based on item response theory (IRT) and Rasch Measurement Theory … evaluations based on clinical trial or observational study data Cross-sectional and longitudinal observational …
… have to be developed in the context of a rapidly evolving disease landscape. As we return to standard reimbursement …
… Drugs Orphan drugs designated and approved for only 1 rare disease or condition Drugs with total spending under Medicare … devalues the life of specific members when determining cost-effectiveness of a treatment and is therefore inherently … to each drug’s manufacturer 1 July 2025: Manufacturer Response Deadline Deadline for manufacturers of selected …
… PCs, and reduce health care costs.” Learn more about the study here . Related Services Health Economics Staff …
… treatment types for CLL and MCL in routine clinical settings, researchers from AstraZeneca and RTI Health … The annual economic burden of adverse events and other disease-related medical costs of CLL alone in the United … research helps provide such evidence to the stakeholders.” Study measures and endpoints were as follows: Baseline …